Your browser doesn't support javascript.
loading
Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.
Pimentel-Quiroz, Victor R; Ugarte-Gil, Manuel F; Pons-Estel, Guillermo J; Soriano, Enrique R; Saurit, Verónica; Sato, Emilia I; Lavras Costallat, Lilian T; Molina, José Fernando; Iglesias-Gamarra, Antonio; Reyes-Llerena, Gil; Neira, Oscar J; Barile, Leonor A; Silveira, Luis H; Segami, María Ines; Chacón-Díaz, Rosa; Wojdyla, Daniel; Alarcón, Graciela S; Pons-Estel, Bernardo A.
Afiliação
  • Pimentel-Quiroz VR; Rheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud, Av. Grau 800, La Victoria, Lima 13, Lima, Peru. Electronic address: victorpq4@gmail.com.
  • Ugarte-Gil MF; Rheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud, Av. Grau 800, La Victoria, Lima 13, Lima, Peru; Universidad Científica del Sur, Lima, Peru.
  • Pons-Estel GJ; Department of Autoimmune Diseases, Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Barcelona, Spain.
  • Soriano ER; Sección de Reumatología, Servicio de Clínica Médica, Hospital Italiano and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires, Argentina.
  • Saurit V; Servicio de Reumatología, Hospital Privado, Centro Medico de Córdoba, Córdoba, Argentina.
  • Sato EI; Departamento de Medicina, Disciplina de Reumatología, Escola Paulista de Medicina, Universidade Federal da São Paulo-UNIFESP, São Paulo, Brazil.
  • Lavras Costallat LT; Disciplina de Reumatología, Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas-UNICAMP, Campinas, Brazil.
  • Molina JF; Reumalab, Centro Integral de Reumatología, Medellín, Colombia.
  • Iglesias-Gamarra A; Departamento de Medicina, Universidad del Bosque, Bogotá, Colombia.
  • Reyes-Llerena G; Servicio de Reumatología, Centro de Investigaciones Médico Quirúrgicas-CIMEQ, Havana, Cuba.
  • Neira OJ; Servicio de Reumatología, Hospital del Salvador, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
  • Barile LA; Servicio de Reumatología, Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.
  • Silveira LH; Departamento de Reumatología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico, Mexico.
  • Segami MI; Servicio de Reumatología, Hospital Nacional Edgardo Rebagliatti Martins, Essalud, Lima, Peru.
  • Chacón-Díaz R; Servicio de Reumatología, Centro Nacional de Enfermedades Reumáticas, Hospital Universitario de Caracas, Caracas, Venezuela.
  • Wojdyla D; Department of Statistic, Associated to GLADEL, Rosario, Argentina.
  • Alarcón GS; Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL.
  • Pons-Estel BA; Servicio de Reumatología, Hospital Provincial de Rosario, Rosario, Argentina.
Semin Arthritis Rheum ; 47(2): 199-203, 2017 10.
Article em En | MEDLINE | ID: mdl-28291583
ABSTRACT

AIMS:

To determine the factors predictive of disease activity early in the course of SLE (baseline visit).

METHODS:

Patients from GLADEL, a multi-national, multi-ethnic, Latin-American lupus cohort were included. Disease activity was evaluated at baseline with the SLEDAI score. Demographic characteristics (age at diagnosis, gender, ethnicity, marital status, educational level, medical coverage and socioeconomic status) were assessed. Disease duration was defined as the time between the fourth ACR criterion and baseline. Time to criteria accrual was defined as the interval between the first and fourth ACR criterion. Use of glucocorticoids was recorded as the highest dose received before the baseline visit. Antimalarials and immunosuppressive drugs were recorded as use or not use. Univariable and multivariable analysis were performed. Model selection was based on backward elimination.

RESULTS:

One thousand two hundred sixty-eight patients were included; 1136 (89.6%) of them were female. Mean age at diagnosis was 29.2 (SD 12.3) years. Five hundred sixty-five (44.6%) were Mestizo, 539 (42.5%) were Caucasians and 164 (12.9%) were African-Latin-Americans. The mean SLEDAI at baseline was 10.9 (SD 8.4). Longer time between first and fourth ACR criterion, medical coverage, a dose of prednisone between 15 and 60mg/d, and the use of antimalarials were factors protective of disease activity, while Mestizo and African-Latin-American ethnicities were predictive factors.

CONCLUSIONS:

Mestizo and African-Latin-American ethnicities were predictive whereas antimalarial use, medical coverage, and longer time to criteria accrual were protective of higher disease activity early in the disease course.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucocorticoides / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucocorticoides / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2017 Tipo de documento: Article